Paul Tudor Jones’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Paul Tudor Jones’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-21,100	Closed	-$744K	–	1810
2015 Q1	$744K	Sell	21,100 -7,510	-26%	-$254K	0.02%	507
2014 Q4	$919K	Buy	28,610 +6,910	+32%	+$200K	0.03%	380
2014 Q3	$609K	Buy	21,700 +1,983	+10%	+$60.4K	0.02%	551
2014 Q2	$596K	Buy	19,717 +4,317	+28%	+$119K	0.02%	442
2014 Q1	$426K	Sell	15,400 -15,798	-51%	-$413K	0.02%	613
2013 Q4	$797K	Buy	31,198 +12,298	+65%	+$379K	0.04%	297
2013 Q3	$565K	Buy	18,900 +900	+5%	+$25K	0.02%	288
2013 Q2	$518K	Buy	+18,000	New	+$496K	0.04%	316

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Paul Tudor Jones's BRLI Position: Q2 2015 in Review

Paul Tudor Jones sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 21,100 shares — an estimated $744K sold.

Paul Tudor Jones first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $919K in Q4 2014. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

Paul Tudor Jones reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
Paul Tudor Jones sold 21,100 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $744K.
Paul Tudor Jones first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Paul Tudor Jones's BIO-REFERENCE LABS INC-NEW- position peaked at $919K in Q4 2014.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Tudor Investment Corp's 13F filing for Q2 2015, filed 14 Aug 2015.